This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ucb Pharma Gmbh. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Paul Deutsch in the Pharmaceutical Field
Introduction
Paul Deutsch is a notable inventor based in Brussels, Belgium, recognized for his innovative contributions to the pharmaceutical industry. With a keen focus on developing new synthesis methods, Deutsch has significantly advanced the field of medicinal chemistry.
Latest Patents
Deutsch holds a patent for a "Process for the preparation of nitrogen substituted aminotetralins derivatives." This invention provides an alternative synthesis for N-substituted aminotetralins, which is essential for pharmaceutical applications. The process involves the resolution of N-substituted aminotetralins of a specific formula, allowing for improved efficiency in the synthesis of crucial compounds.
Career Highlights
Currently affiliated with UCB Pharma GmbH, Paul Deutsch has established himself as an influential figure in pharmaceutical research and development. His work emphasizes the importance of innovative solutions in the creation of new therapeutic agents.
Collaborations
At UCB Pharma, Deutsch collaborates with talented individuals such as Celal Ates and Arnaud Schule. These partnerships reflect a commitment to fostering a collaborative environment that enhances creativity and drives innovation within the company.
Conclusion
Paul Deutsch’s pioneering work in the synthesis of nitrogen-substituted aminotetralins derivatives showcases his significant contributions to the field of pharmaceuticals. As an inventor, his dedication to innovation continues to inspire future research and development initiatives within the industry.